Dr. Eric Jonasch, MD
Claim this profileM D Anderson Cancer Center
Studies Renal Cell Carcinoma
Studies Kidney Cancer
11 reported clinical trials
15 drugs studied
Area of expertise
1Renal Cell Carcinoma
Stage IV
Stage III
2Kidney Cancer
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Eric Jonasch, MD is currently running
177Lu Girentuximab + Cabozantinib + Nivolumab
for Advanced Renal Cell Carcinoma
To learn if giving 177Lu girentuximab in combination with cabozantinib plus nivolumab can help to control advanced clear cell renal cell carcinoma (ccRCC).
Recruiting1 award Phase 1 & 211 criteria
PRO1160
for Advanced Cancer
This trial tests PRO1160, a targeted cancer treatment, in patients with advanced or hard-to-remove cancers. PRO1160 uses an antibody to find cancer cells and a drug to kill them.
Recruiting1 award Phase 1 & 25 criteria
More about Eric Jonasch, MD
Clinical Trial Related1 year of experience running clinical trials · Led 11 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Eric Jonasch, MD has experience with
- Nivolumab
- Ipilimumab
- Nephrectomy
- Sunitinib
- 177Lu Girentuximab
- Cabozantinib
Breakdown of trials Eric Jonasch, MD has run
Renal Cell Carcinoma
Kidney Cancer
Skin Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Eric Jonasch, MD specialize in?
Eric Jonasch, MD focuses on Renal Cell Carcinoma and Kidney Cancer. In particular, much of their work with Renal Cell Carcinoma has involved Stage IV patients, or patients who are Stage III.
Is Eric Jonasch, MD currently recruiting for clinical trials?
Yes, Eric Jonasch, MD is currently recruiting for 4 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Eric Jonasch, MD has studied deeply?
Yes, Eric Jonasch, MD has studied treatments such as Nivolumab, Ipilimumab, Nephrectomy.
What is the best way to schedule an appointment with Eric Jonasch, MD?
Apply for one of the trials that Eric Jonasch, MD is conducting.
What is the office address of Eric Jonasch, MD?
The office of Eric Jonasch, MD is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.